Business Insider

Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden

Gradalis, Inc., a clinical-stage biotechnology company focused on personalized anti-cancer therapy for patients with ovarian and other cancers, announced a peer-reviewed publication in Scientific ...

Low-cost genome sequencing approach is powering genetics research on mental illness and many other studies

For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...
The American Journal of Managed Care

Whole Exome Sequencing Identifies Distinct Profile of Transformed SCLC

Transformed SCLC from EGFR-mutated LUAD shows a unique mutational profile, complicating treatment approaches and highlighting the need for tailored therapies. Whole exome sequencing revealed ...
News Medical

Scientists use whole exome sequencing to discover a new rare genetic disease

Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators used a genetic sequencing technique called whole exome sequencing to discover a new rare ...
ascopubs.org

Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden–High Ovarian Cancer

Genomic Profile and Resistance to Anti-Epidermal Growth Factor Receptor Antibody in RAS-Amplified Colorectal Cancer: A Study Based on a Japanese Cancer Genome Database Frontline ovarian cancer ...